Why HALO? Halozyme Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
HALO
$66.35+0.48 (+0.73%)
Pre-Market$65.48-0.87 (-1.31%)· Last close May 6
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.